PDF(Pubmed)
Abstract：
UNASSIGNED: The number of patients with chronic limb-threatening ischemia has increased in recent years. Herein, we report a rare case of angioplasty with a bovine pericardial patch in a patient with severe stenosis of the common femoral artery.
METHODS: We report a case of a 73-year-old female with intermittent claudication. Ankle-brachial index (ABI) measurements showed a significant decrease of 0.52 on the left, and angiography revealed total occlusion on the left common femoral artery (CFA). Considering additional skin incisions, postoperative wound infection, and potential graft sampling, endarterectomy of the left CFA and patch angioplasty with the bovine pericardium (XenoSure®) were performed. The operative computed tomography showed no stenosis and the ABI improved from 0.52 to 1.15. Additionally, no stenosis, calcification, or dilatation was observed during the follow-up one year after the operation.
UNASSIGNED: Various types of peripheral arterial repair were performed after endarterectomy. Autologous vein grafts and vascular prostheses are frequently used considering the background of each patient. Using bovine pericardium over other devices has several advantages, including no additional skin incisions to obtain the patches, resistance to infection, no oozing from the device itself, less bleeding from the suture site, and ease of hemostasis after the puncture under additional endovascular treatment. This case may be a good implication when deciding which device to use in complicated patients.
CONCLUSIONS: This case provides valuable insight into successful patch angioplasty after endarterectomy without any complications, highlighting the utility of XenoSure® in the treatment of this disease.
METHODS: We report a case of a 73-year-old female with intermittent claudication. Ankle-brachial index (ABI) measurements showed a significant decrease of 0.52 on the left, and angiography revealed total occlusion on the left common femoral artery (CFA). Considering additional skin incisions, postoperative wound infection, and potential graft sampling, endarterectomy of the left CFA and patch angioplasty with the bovine pericardium (XenoSure®) were performed. The operative computed tomography showed no stenosis and the ABI improved from 0.52 to 1.15. Additionally, no stenosis, calcification, or dilatation was observed during the follow-up one year after the operation.
UNASSIGNED: Various types of peripheral arterial repair were performed after endarterectomy. Autologous vein grafts and vascular prostheses are frequently used considering the background of each patient. Using bovine pericardium over other devices has several advantages, including no additional skin incisions to obtain the patches, resistance to infection, no oozing from the device itself, less bleeding from the suture site, and ease of hemostasis after the puncture under additional endovascular treatment. This case may be a good implication when deciding which device to use in complicated patients.
CONCLUSIONS: This case provides valuable insight into successful patch angioplasty after endarterectomy without any complications, highlighting the utility of XenoSure® in the treatment of this disease.
摘要：
■近年来，慢性威胁肢体缺血的患者人数有所增加。在这里，我们报道了一例罕见的股总动脉严重狭窄患者用牛心包补片进行血管成形术。
方法：我们报告一例73岁女性间歇性跛行。踝臂指数（ABI）测量显示左侧显著下降0.52，血管造影显示左股总动脉（CFA）完全闭塞。考虑到额外的皮肤切口，术后伤口感染,和潜在的移植物取样，进行左CFA的动脉内膜切除术和用牛心包(XenoSure®)的补片血管成形术。手术计算机断层扫描显示无狭窄，ABI从0.52改善至1.15。此外,没有狭窄,钙化,术后1年随访观察到扩张。
■动脉内膜切除术后进行各种类型的外周动脉修复。考虑到每个患者的背景，经常使用自体静脉移植物和血管假体。使用牛心包而不是其他设备有几个优点，包括没有额外的皮肤切口来获得补丁，抵抗感染,设备本身没有渗出，缝合部位出血减少，在额外的血管内治疗下，穿刺后易于止血。在决定在复杂患者中使用哪种设备时，这种情况可能是一个很好的暗示。
结论：本病例提供了对动脉内膜切除术后成功的补片血管成形术无任何并发症的宝贵见解，强调XenoSure®在治疗这种疾病中的实用性。
方法：我们报告一例73岁女性间歇性跛行。踝臂指数（ABI）测量显示左侧显著下降0.52，血管造影显示左股总动脉（CFA）完全闭塞。考虑到额外的皮肤切口，术后伤口感染,和潜在的移植物取样，进行左CFA的动脉内膜切除术和用牛心包(XenoSure®)的补片血管成形术。手术计算机断层扫描显示无狭窄，ABI从0.52改善至1.15。此外,没有狭窄,钙化,术后1年随访观察到扩张。
■动脉内膜切除术后进行各种类型的外周动脉修复。考虑到每个患者的背景，经常使用自体静脉移植物和血管假体。使用牛心包而不是其他设备有几个优点，包括没有额外的皮肤切口来获得补丁，抵抗感染,设备本身没有渗出，缝合部位出血减少，在额外的血管内治疗下，穿刺后易于止血。在决定在复杂患者中使用哪种设备时，这种情况可能是一个很好的暗示。
结论：本病例提供了对动脉内膜切除术后成功的补片血管成形术无任何并发症的宝贵见解，强调XenoSure®在治疗这种疾病中的实用性。
